# ü´Å Lung Fibrosis scRNA-seq Analysis (GSE141259) - Day 1

**Date:** 16-1-2026
**Project:** Lung Regeneration & Fibrosis (Bleomycin Model)  
**Author:** Nora

---

## üìù Summary
This document records the progress of Day 1 analysis using the `GSE141259` dataset. The workflow covers raw data preprocessing, quality control, integration of author-provided annotations, and preliminary investigation of cell type dynamics during disease progression (PBS vs. Bleomycin time course).
Êú¨ÊñáÊ°£ËÆ∞ÂΩï‰∫ÜÂü∫‰∫é `GSE141259` Êï∞ÊçÆÈõÜÁ¨¨‰∏ÄÂ§©ÁöÑÂàÜÊûêËøõÂ∫¶„ÄÇÂ∑•‰ΩúÊµÅÁ®ãÊ∂µÁõñ‰∫ÜÂéüÂßãÊï∞ÊçÆÈ¢ÑÂ§ÑÁêÜ„ÄÅË¥®ÈáèÊéßÂà∂„ÄÅ‰ΩúËÄÖÊ≥®Èáä‰ø°ÊÅØÁöÑÊï¥ÂêàÔºå‰ª•ÂèäÂØπÁñæÁóÖËøõÁ®ãÔºàPBS ÂØπÁÖßÁªÑ‰∏éÂçöÊù•ÈúâÁ¥†Êçü‰º§ÁªÑÁöÑÊó∂Èó¥Â∫èÂàóÔºâ‰∏≠ÁªÜËÉûÁ±ªÂûãÂä®ÊÄÅÁöÑÂàùÊ≠•Êé¢Á©∂„ÄÇ

---

## üìÇ Repository Structure
* **`01_preprocessing_standard.R`**: Script for loading raw counts, QC, normalization, and metadata integration. (Êï∞ÊçÆÂä†ËΩΩ„ÄÅË¥®Êéß„ÄÅÊ†áÂáÜÂåñÂèäÂÖÉÊï∞ÊçÆÊï¥ÂêàËÑöÊú¨)
* **`02_disease_comparison.R`**: Script for visualizing disease progression and validating marker genes. (ÁñæÁóÖËøõÁ®ãÂèØËßÜÂåñÂèäÊ†áÂøóÁâ©È™åËØÅËÑöÊú¨)

---

## üõ†Ô∏è Workflow & Achievements

### Part 1: Data Preprocessing & Authorization
* **Setup Seurat Object**: Successfully loaded the raw count matrix and initialized the Seurat object.
    * *ÊàêÂäüÂä†ËΩΩÂéüÂßãËÆ°Êï∞Áü©ÈòµÂπ∂ÂàùÂßãÂåñ Seurat ÂØπË±°„ÄÇ*
* **Metadata Correction**: Corrected `orig.ident` from the auto-parsed "muc4169" to the project label "lianxixi".
    * *‰øÆÊ≠£ÂÖÉÊï∞ÊçÆÔºöÂ∞ÜËá™Âä®Ëß£ÊûêÁöÑ "muc4169" Ê†áÁ≠æÊõ¥Êîπ‰∏∫È°πÁõÆÊ†áÁ≠æ "lianxixi"„ÄÇ*
* **Annotation Integration**: Loaded author-provided metadata (`GSE141259_WholeLung_cellinfo.csv`) and mapped cell types to the object. Handled `NA` values by assigning them as "Unknown".
    * *Ê≥®ÈáäÊï¥ÂêàÔºöÂä†ËΩΩ‰ΩúËÄÖÊèê‰æõÁöÑÂÖÉÊï∞ÊçÆÊñá‰ª∂ÔºåÂ∞ÜÁªÜËÉûÁ±ªÂûãÊò†Â∞ÑÂà∞ÂØπË±°‰∏≠ÔºåÂπ∂Â∞ÜÁº∫Â§±ÂÄºÊ†áËÆ∞‰∏∫ "Unknown"„ÄÇ*
* **Dimensionality Reduction**: Performed standard normalization, scaling, PCA, and UMAP visualization.
    * *ÈôçÁª¥ÂàÜÊûêÔºöÂÆåÊàêÊ†áÂáÜÂåñÁöÑÂΩí‰∏ÄÂåñ„ÄÅÁº©Êîæ„ÄÅPCA Âèä UMAP ÂèØËßÜÂåñ„ÄÇ*

### Part 2: Disease Progression Analysis
* **Time-Course Grouping**: Identified 7 experimental groups: `PBS` (Control) and `d3, d7, d10, d14, d21, d28` (Bleomycin injury model).
    * *Êó∂Èó¥Â∫èÂàóÂàÜÁªÑÔºöËØÜÂà´Âá∫ 7 ‰∏™ÂÆûÈ™åÁªÑÔºöPBSÔºàÂØπÁÖßÔºâÂèä d3-d28ÔºàÂçöÊù•ÈúâÁ¥†Êçü‰º§Ê®°ÂûãÔºâ„ÄÇ*
* **Dynamics Visualization**:
    * **Split UMAP**: Visualized cell shifts across time points. (*ÊãÜÂàÜ UMAP ÂõæÔºöÂèØËßÜÂåñÁªÜËÉûÈöèÊó∂Èó¥ÁöÑËøÅÁßª„ÄÇ*)
    * **Trend Lines**: Plotted proportion changes for key cell types (AM, AT2, Krt8 ADI). (*ÊäòÁ∫øÂõæÔºöÁªòÂà∂ÂÖ≥ÈîÆÁªÜËÉûÁ±ªÂûãÁöÑÊØî‰æãÂèòÂåñË∂ãÂäø„ÄÇ*)
* **Marker Validation (Krt8 Story)**:
    * Verified `Sftpc` (AT2 marker) loss and `Krt8` (injury marker) emergence using **FeaturePlots**.
    * Confirmed `Krt8` expression specifically in the **Krt8 ADI** population (and normal airway cells) but NOT in healthy AT2 cells using **Violin Plots**.
    * *Ê†áÂøóÁâ©È™åËØÅÔºö‰ΩøÁî®ÁâπÂæÅÂõæÈ™åËØÅ‰∫Ü Sftpc ÁöÑ‰∏¢Â§±Âíå Krt8 ÁöÑÂá∫Áé∞Ôºõ‰ΩøÁî®Â∞èÊèêÁê¥ÂõæËØÅÂÆû Krt8 ÁâπÂºÇÊÄßË°®Ëææ‰∫éÊçü‰º§ÂêéÁöÑ Krt8 ADI ÁªÜËÉûÁæ§ÔºàÂèäÊ≠£Â∏∏Ê∞îÁÆ°ÁªÜËÉûÔºâÔºåËÄåÂú®ÂÅ•Â∫∑ AT2 ÁªÜËÉû‰∏≠‰∏çË°®Ëææ„ÄÇ*

---

## üìä Key Findings
1.  **Cellular Shift**: A massive infiltration of macrophages and loss of AT2 cells were observed starting from day 3.
    * *ÁªÜËÉûÊºîÂèòÔºö‰ªéÁ¨¨ 3 Â§©ÂºÄÂßãËßÇÂØüÂà∞Â∑®Âô¨ÁªÜËÉûÁöÑÂ§ßÈáèÊµ∏Ê∂¶Âíå AT2 ÁªÜËÉûÁöÑ‰∏¢Â§±„ÄÇ*
2.  **Emergence of Krt8+ Cells**: A distinct `Krt8 ADI` population appears around d10-d14, coinciding with the peak of tissue injury.
    * *Krt8+ ÁªÜËÉûÁöÑÂá∫Áé∞ÔºöÂú® d10-d14ÔºàÁªÑÁªáÊçü‰º§È´òÂ≥∞ÊúüÔºâËßÇÂØüÂà∞ÊòéÊòæÁöÑ `Krt8 ADI` ÁªÜËÉûÁæ§„ÄÇ*
3.  **Molecular Validation**: Confirmed that `Krt8 ADI` cells express high levels of *Krt8*, distinguishing them from healthy alveolar type 2 cells.
    * *ÂàÜÂ≠êÈ™åËØÅÔºöËØÅÂÆû `Krt8 ADI` ÁªÜËÉûÈ´òË°®Ëææ *Krt8*ÔºåÂ∞ÜÂÖ∂‰∏éÂÅ•Â∫∑ÁöÑËÇ∫Ê≥°‰∫åÂûãÁªÜËÉûÂå∫ÂàÜÂºÄÊù•„ÄÇ*

---

## üîú Next Steps
* Perform Differential Expression Analysis (DEG) to identify genes driving the AT2-to-Krt8 transition.
    * *ËøõË°åÂ∑ÆÂºÇË°®ËææÂàÜÊûê (DEG)ÔºåÂØªÊâæÈ©±Âä® AT2 Âêë Krt8 Áä∂ÊÄÅËΩ¨ÂèòÁöÑÂÖ≥ÈîÆÂü∫Âõ†„ÄÇ*

---
# üìÇ Work Log: Differential Expression Analysis (Krt8 ADI vs AT2)

**Date:** 2026-01-17  
**Author:** Nora  
**Script:** `03_scripts_runs/03_DEG_analysis.R`  
**Data Source:** GSE141259 (Mouse Lung Fibrosis Model)

---

## üéØ 1. Objective
To identify the molecular mechanisms driving the transition from healthy **AT2 cells** to the pathological **Krt8 ADI (Alveolar Differentiation Intermediate)** state. Specifically, to find Differentially Expressed Genes (DEGs) that characterize the "dedifferentiation" and "stress response" process.

## üõ†Ô∏è 2. Workflow
* **Data Loading:** Loaded the processed Seurat object (`lung_obj_final_analysis.rds`).
* **Set Identity:** Switched active identity to `cell.type`.
* **DEG Calculation:** Used `FindMarkers()` to compare `Krt8 ADI` (Group 1) vs `AT2 cells` (Group 2).
* **Visualization:** Generated Volcano Plots and UMAP Feature Plots to validate findings spatially.

## üß¨ 3. Key Biological Findings

Through statistical analysis and spatial visualization, three key dimensions of the Krt8 ADI cell state were identified:

### A. Identity Switch
* **Loss of AT2 Marker:** `Sftpc` (Surfactant Protein C) was significantly **downregulated** (Log2FC ‚âà -2.5), indicating a loss of normal alveolar function (Dedifferentiation).
* **Gain of Injury Marker:** `Krt8` (Cytokeratin 8) was significantly **upregulated** (Log2FC ‚âà 3.16), serving as the distinct marker for this injury-associated cell state.

### B. Cellular Senescence
* **Cycle Arrest:** `Cdkn1a` (p21) was highly upregulated (Top 10 upregulated genes). This suggests the cells are locked in a senescent state (cell cycle arrest) and unable to complete regeneration.

### C. Stress Response
* **High Stress Level:** `S100a6` and `Clu` (Clusterin) showed the most dramatic upregulation (Log2FC > 5). This reflects an intense survival response to tissue injury.

## üìä 4. Visual Evidence

| Plot Type | Filename | Description |
| :--- | :--- | :--- |
| **Volcano Plot** | `lianxixi_Volcano_Krt8_Final.png` | Highlights the global shift: Sftpc (Left/Down) vs Krt8/S100a6/Cdkn1a (Right/Up). |
| **Feature Plot** | `lianxixi_FeaturePlot_KeyGenes.png` | Spatial confirmation: `Krt8` expression is exclusive to the specific "bridge" population where `Sftpc` expression is lost, co-localizing perfectly with stress markers `S100a6` and `Cdkn1a`. |

## üìù 5. Conclusion
The analysis confirms that **Krt8 ADI cells** are not merely "different" AT2 cells, but a distinct, pathological cell state characterized by **dedifferentiation (loss of Sftpc)**, **senescence (Cdkn1a)**, and **high stress (S100a6)**. They represent a "stalled" regeneration intermediate in lung fibrosis.

---
*Created with R Seurat v4/v5*

---

# üß¨ Work Log: Functional Enrichment Analysis (GO:BP)

**Date:** 2026-01-19  
**Author:** Nora  
**Script:** `03_scripts_runs/04_Enrichment_analysis.R`  
**Input Data:** Up-regulated DEGs from Krt8 ADI cells (vs AT2)

## üéØ 1. Objective
To decode the functional state of **Krt8 ADI cells** by mapping the previously identified up-regulated genes (e.g., *Krt8*, *S100a6*, *Clu*) to biological pathways using Gene Ontology (GO) enrichment analysis. We aim to answer: "What are these damaged cells actively *doing*?"

## üõ†Ô∏è 2. Methodology
* **Filtering:** Selected significant up-regulated genes (`adj.P.Val < 0.05` & `log2FC > 0.5`) from the DEG table.
* **Annotation:** Converted Gene Symbols to Entrez IDs using `org.Mm.eg.db`.
* **Enrichment:** Performed GO Biological Process (BP) enrichment using `clusterProfiler::enrichGO`.
* **Visualization:** Generated a Dotplot to visualize the top 15 most significant pathways.

## üß¨ 3. Key Findings
The analysis reveals that Krt8 ADI cells are metabolically hyper-active despite being cell-cycle arrested.

### A. Hyper-Biosynthesis
* **Top Terms:** `cytoplasmic translation`, `ribosome biogenesis`, `translation at synapse`.
* **Interpretation:** The most significant function is **protein synthesis**. This explains the high expression of structural proteins (*Krt8*) and stress-response proteins (*S100a6*, *Clu*) identified in the previous step. The cells are effectively "factories" running at full capacity to produce survival factors.

### B. High Metabolic Demand
* **Key Terms:** `aerobic respiration`, `oxidative phosphorylation`, `ATP synthesis`.
* **Interpretation:** The protein synthesis machinery requires immense energy. The enrichment of respiratory pathways confirms that these cells are burning fuel (ATP) aggressively to maintain their "stalled" but highly active stress state.

## üìä 4. Visual Evidence

| Plot Type | Filename | Description |
| :--- | :--- | :--- |
| **Dotplot** | `GO_Enrichment_Dotplot.png` | Shows the top enriched biological processes. The dominance of "Translation" (Red/Large bubbles) provides strong evidence for the high-biosynthetic state of Krt8 ADI cells. |

## üìù 5. Integrated Conclusion
Combining the DEG results (Jan 17) with today's Enrichment results (Jan 19):
**Krt8 ADI cells** are defined by a paradox:
1.  **Stalled Growth:** They are not dividing (high *Cdkn1a*).
2.  **Hyper-Active Metabolism:** They are actively synthesizing proteins and generating ATP (GO results).
This confirms they are in a **Senescence-Associated Secretory Phenotype (SASP)-like state**, prioritizing survival and stress signaling over regeneration.

---
*Created with clusterProfiler / R*

---
# üß¨ Work Log: Trajectory & Pseudotime Analysis (Monocle3)

**Date:** 2026-01-26  
**Author:** Nora  
**Script:** `05_Trajectory_Analysis.R`  
**Input Data:** Seurat Object (`lung_obj_final_analysis.rds`) - Subset of AT2 & ADI lineages.

---

## üéØ 1. Objective

To reconstruct the continuous developmental trajectory of alveolar regeneration and quantify the transdifferentiation process from healthy **AT2 cells** to the injury-induced **Krt8+ ADI** state.
We aim to answer: *"Is there a continuous path connecting these two states, and what are the driver genes orchestrating this transition?"*

---

## üõ†Ô∏è 2. Methodology

The analysis was performed using **Monocle3** with the following key steps:

* **Data Structure Conversion:** Successfully converted the Seurat object to Monocle3 `cell_data_set` (CDS).
    * *Correction:* Manually transferred `cell_type` metadata to resolve the ID matching error.
* **Trajectory Inference:** Learned the principal graph on the UMAP embedding.
    * *Result:* A continuous "main path" was identified connecting the AT2 cluster to the ADI cluster.
* **Pseudotime Calculation:**
    * Defined the **Root Node** based on the highest density of `AT2 cells`.
    * Calculated pseudotime values for all cells (0 = Start/AT2, >50 = End/ADI).
* **Driver Gene Identification:**
    * Used **Moran‚Äôs I test** (`graph_test`) to find genes with spatially coherent expression along the trajectory.
    * Grouped these genes into **Co-expression Modules** to identify the ADI-specific gene signature.

---

## üß¨ 3. Key Findings

### A. Confirmation of Lineage Plasticity
The trajectory analysis confirms a direct, continuous lineage relationship between AT2 cells and Krt8 ADI cells. The process is not discrete but shows a gradual transition, supporting the hypothesis of **AT2-to-ADI transdifferentiation**.

### B. Pseudotime Gradient
* **Early Phase:** Corresponds to naive AT2 cells (High expression of surfactant genes).
* **Late Phase:** Corresponds to the Krt8 ADI state, characterized by the loss of AT2 identity and acquisition of a stress/injury phenotype.

### C. Identification of the "ADI Module"
We successfully identified a specific gene module that is sharply upregulated at the trajectory terminus (ADI state).
* **Key Markers identified:** `Krt8`, `Krt19`, `Lgals3`.
* **Biological Implication:** This module represents the core transcriptional machinery driving the injury response and preventing re-differentiation (the "stalled" state).

---

## üìä 4. Visual Evidence 

| Plot Type | Filename | Description |
| :--- | :--- | :--- |
| **Trajectory** | `Monocle3_Trajectory_Initial.png` | Visualization of the learned black line (principal graph) on UMAP. |
| **Pseudotime** | `Monocle3_Pseudotime_Final.png` | Cells colored by pseudotime (Purple -> Yellow) showing the direction of differentiation. |
| **Heatmap** | `Monocle3_Heatmap_Modules.png` | Heatmap of gene modules, revealing the specific group of genes activated at the end of the trajectory. |
| **Gene List** | `Krt8_ADI_Module_Genes.csv` | **[Important]** The full list of genes co-expressed with Krt8 (The "Suspect List"). |

---

## üìù Next Steps
* Perform functional enrichment analysis (GO/KEGG) on the identified "Krt8 Module" to understand the biological functions (e.g., wound healing, senescence).

---
# üìÖ 2026-01-27: Functional Enrichment Analysis (GO Terms)

**Script:** `06_Module_Enrichment.R`
**Input Data:** `Krt8_ADI_Module_Genes.csv` (The target gene list identified in Step 05)
**Status:** ‚úÖ Completed

## üéØ 1. Objective
To decode the biological function of the "Krt8 ADI Module".
We know *which* genes are in this module (e.g., *Krt8*, *Lgals3*), but we need to understand *what* cellular processes they orchestrate.
* **Question:** Are these cells dying? Proliferating? Or differentiating?

## üõ†Ô∏è 2. Methodology
* **Tool:** `clusterProfiler` (R package).
* **Database:** `org.Mm.eg.db` (Mouse Genome).
* **Analysis Type:** Gene Ontology (GO) Enrichment - **Biological Process (BP)**.
* **Process:**
    1.  Converted Gene Symbols to Entrez IDs.
    2.  Performed enrichment test (p-value cutoff < 0.05).
    3.  Visualized top 15 enriched terms using a **Dotplot**.

## üß¨ 3. Key Findings
The analysis reveals a distinct "Reprogramming & Repair" signature:

1.  **Squamous Metaplasia:**
    * **Top Terms:** `epidermis development`, `skin development`.
    * **Interpretation:** The lung AT2 cells are adopting "skin-like" properties (expression of Keratins). This is a classic stress response to thicken the alveolar barrier and protect against injury (forming a "callus").
2.  **Barrier Reconstruction:**
    * **Top Terms:** `tight junction assembly`, `cell-cell junction organization`.
    * **Interpretation:** The cells are actively building connections to seal the injured alveoli and prevent leakage.
3.  **Regenerative Potential :**
    * **Top Terms:** `lung morphogenesis`, `epithelial tube branching`.
    * **Interpretation:** Despite the injury phenotype, the cells retain the developmental memory required to regenerate lung structure.

## üìä 4. Output Files
* üñºÔ∏è **Visualization:** `Krt8_Module_GO_Enrichment.png` (The Dotplot).
* üìã **Full Table:** `Krt8_Module_GO_Table.csv` (Detailed statistics for all terms).

> **Conclusion:** The Krt8 ADI state represents a **"Barrier-Strengthening & Repair"** phase, characterized by the transient activation of epidermal programs to survive acute injury.


---
# üìÖ 2026-01-27: Pseudotime Expression Kinetics (Gene Trends)

**Script:** `07_Gene_Trends.R`
**Input Data:** `lung_monocle_final.rds`
**Status:** ‚úÖ Completed

## üéØ 1. Objective
To visualize the dynamic expression changes of specific marker genes along the inferred trajectory.
We aim to validate the identity switch from AT2 to ADI at the single-gene level: *"Do AT2 markers actually drop? Do ADI markers actually rise?"*

## üõ†Ô∏è 2. Methodology
* **Function:** `monocle3::plot_genes_in_pseudotime`.
* **Target Genes Selected:**
    * **AT2 Lineage:** *Sftpc, Sftpb* (Surfactant proteins).
    * **ADI/Injury Lineage:** *Krt8, Krt19, Lgals3* (Stress markers).
    * **Proliferation:** *Mki67* (Cell cycle marker).
* **Visualization:** Modeled expression trends (black lines) overlaid on single-cell expression values (colored dots).

## üß¨ 3. Key Findings
The kinetic plots reveal distinct expression patterns confirming the transdifferentiation model:

1.  **Loss of AT2 Identity (Sftpc/Sftpb):**
    * **Trend:** Sharp, monotonic decrease along pseudotime.
    * **Meaning:** Cells rapidly silence their surfactant production programs upon injury.
2.  **Gain of Injury State (Krt8/Krt19):**
    * **Trend:** While the smoothed average line remains low (due to zero-inflation/dropout), a distinct sub-population of cells at the terminus (Yellow phase) shows high expression (dots > 3.0).
    * **Meaning:** A specific subset of cells successfully acquires the ADI phenotype.
3.  **Transient Driver (Lgals3):**
    * **Trend:** Strong, bell-shaped upregulation during the intermediate phase.
    * **Meaning:** *Lgals3* appears to be a robust driver activated during the transition process.
4.  **No Proliferation (Mki67):**
    * **Trend:** Flat/Low expression throughout.
    * **Meaning:** Confirms the ADI state is a result of direct conversion (transdifferentiation) without active cell division (cell cycle arrest).

## üìä 4. Output Files
* üñºÔ∏è **Trend Plot:** `Monocle3_Gene_Trends_LinePlot.png` (Visualization of the 6 key genes).

> **Conclusion:** The gene kinetics provide molecular evidence for the AT2-to-ADI transition, characterized by the synchronized downregulation of homeostatic genes and upregulation of stress-response genes.



---
# üìÖ 2026-02-02: Cell-Cell Communication Inference (Global Network)

**Script:** `08_CellChat_Analysis.R`
**Input Data:** `lung_obj_final_analysis.rds` (Seurat Object)
**Status:** ‚úÖ Completed

## üéØ 1. Objective
To infer the intercellular communication network governing the lung injury response.
We aim to move beyond single-cell identify (AT2 vs. ADI) and understand the **social network** of the tissue: *"Who is signaling to whom during the regeneration process?"*

## üõ†Ô∏è 2. Methodology
* **Tool:** `CellChat` (v1.x).
* **Database:** `CellChatDB.mouse` (Full database).
* **Process:**
    1.  **Preprocessing:** Identified over-expressed ligands and receptors in each cell group.
    2.  **Inference:** Computed communication probabilities using the `triMean` method.
    3.  **Aggregation:** Aggregated all L-R pairs to visualize the total communication flow.

## üß¨ 3. Key Findings
* **High Connectivity:** The global network reveals a dense, complex web of interactions (the "Hairball" phenotype), indicating robust cross-talk between Epithelial (AT2/ADI), Immune (Macrophages), and Stromal (Fibroblasts) compartments.
* **Distinction:**
    * **Number Plot:** Shows potential connectivity bandwidth (how many pathways are available).
    * **Weight Plot:** Shows actual signaling intensity (how active these pathways are).

## üìä 4. Output Files
* üíæ **CellChat Object:** `lung_cellchat.rds` (Saved for downstream analysis).
* üñºÔ∏è **Global Networks:**
    * `CellChat_Net_Number.png` (Interaction Frequency).
    * `CellChat_Net_Weights.png` (Interaction Strength).
    * ---
# üìÖ 2026-02-02 (Part 2): Ligand-Receptor Specifics (Zoom-in Analysis)

**Script:** `08_CellChat_Analysis.R` (Part 2)
**Status:** ‚úÖ Completed

## üéØ 1. Objective
To decode the specific molecular signals driving the AT2-to-ADI transition.
Instead of looking at the global network, we perform a directed analysis to answer two specific questions:
1.  **Incoming:** What signals from the microenvironment are "bullying" AT2 cells?
2.  **Outgoing:** What pathogenic signals are Krt8 ADI cells spreading to their neighbors?

## üõ†Ô∏è 2. Methodology
* **Visualization:** `netVisual_bubble` (Bubble Plots).
* **Strategy:**
    * **Input Analysis:** Targets restricted to "AT2 cells".
    * **Output Analysis:** Sources restricted to "Krt8 ADI".
* **Key Metrics:** Ligand-Receptor pairs plotted by communication probability (bubble size) and expression level (color).

## üß¨ 3. Key Findings

### A. Environment Stress on AT2 (Incoming)
* **Key Signal:** `Fn1 - Sdc4` (Fibronectin - Syndecan-4).
* **Senders:** Fibroblasts, Myofibroblasts, and Fn1+ Macrophages.
* **Interpretation:** AT2 cells are being subjected to intense **Extracellular Matrix (ECM) signaling**. The high interaction with Fibronectin (`Fn1`) suggests that **mechanical stress/stiffening** of the niche is a primary driver forcing AT2 cells to lose their identity and undergo reprogramming.

### B. Pro-inflammatory Feedback by ADI (Outgoing)
* **Key Signals:** `Mif - (Cd74+...)` and `Spp1 - Cd44`.
* **Receivers:** Macrophages (AM, M2) and Proliferating cells.
* **Interpretation:** The Krt8 ADI state is not passive. It actively secretes potent pro-inflammatory mediators:
    * **MIF** (Macrophage Migration Inhibitory Factor): Keeps immune cells trapped and active in the injury site.
    * **SPP1** (Osteopontin): A known driver of fibrosis and inflammation.
    * **Conclusion:** ADI cells create a **pathogenic feed-forward loop**, preventing inflammation resolution.

## üìä 4. Output Files
* üñºÔ∏è `CellChat_Incoming_AT2.png`: Shows the fibrotic signals received by AT2.
* üñºÔ∏è `CellChat_Outgoing_ADI.png`: Shows the inflammatory signals sent by ADI.

> **Summary:** The analysis identifies the **Fn1-Sdc4 axis** as a potential upstream trigger for AT2 injury, and the **Mif/Spp1 axis** as a downstream consequence of the ADI state.

> **Next Step:** Perform "Sender/Receiver" analysis to specifically zoom in on signals received by AT2 cells (Input) and signals sent by Krt8 ADI cells (Output).


# üìÖ 2026-02-07 (Part 3): Transcription Factor Analysis (The "Master Regulators")

**Script:** `09_TF_Analysis_decoupleR.R` (Final AutoFix Version)
**Status:** ‚úÖ Completed (High Difficulty)

## üéØ 1. Objective
To move beyond gene expression and identify the **upstream Transcription Factors (TFs)** controlling the AT2-to-ADI transition. We aim to find the "bosses" (TFs) in the nucleus that are orchestrating the reprogramming process.

## üõ†Ô∏è 2. Methodology
* **Tool:** `decoupleR` (R package for footprint analysis).
* **Algorithm:** `run_ulm` (Univariate Linear Model) for fast and robust inference.
* **Database:** `DoRothEA` (High-confidence TF-Target interactome).
* **Process:**
    * Inferred TF activity scores based on the aggregate expression of downstream target genes.
    * **Troubleshooting:** Overcame persistent "cell name mismatch" errors by implementing a robust renaming strategy (renaming all cells to `C1`, `C2`...) to ensure 100% matrix alignment.

## üß¨ 3. Key Findings

### A. The Mastermind of Reprogramming
* **Key TF:** **Sox9**.
* **Observation:** Shows peak activity (deep red) specifically in `Krt8 ADI` cells, while silent in normal AT2 cells.
* **Interpretation:** **Sox9** is confirmed as the master regulator forcing AT2 cells to lose their identity and acquire a progenitor-like state.

### B. The Stress Signal (The Trigger)
* **Key TFs:** **Atf6** and **Hsf1**.
* **Observation:** Highly upregulated activity in the ADI population.
* **Interpretation:** Markers of **ER Stress (Unfolded Protein Response)**. This suggests that proteotoxic stress is a primary driver or consequence of the transition.

### C. The Fibrosis Architects (EMT)
* **Key TF:** **Twist1**.
* **Interpretation:** **Twist1** is a classic driver of Epithelial-Mesenchymal Transition (EMT). Its activation indicates AT2 cells are acquiring fibroblast-like properties, contributing to fibrosis.

### D. The Inflammatory Thugs
* **Key TFs:** **Junb**, **Fosl1** (AP-1 family).
* **Interpretation:** Indicates a strong pro-inflammatory transcriptional program is active within the transitioning cells.

## üìä 4. Output Files
* üñºÔ∏è `TF_Activity_Heatmap.png`: Heatmap visualizing the inferred activity of the top differential TFs across all cell types.

> **Summary:** The analysis successfully identifies the **Sox9-Twist1-Atf6 axis** as the core regulatory network. Injury triggers **ER Stress (Atf6)**, which activates **Sox9** for reprogramming and **Twist1** for fibrosis.

**Next Step:** Perform Pathway Activity Analysis (PROGENy/UCell) to score specific biological processes (e.g., Hypoxia, TGF-b signaling) across the trajectory.


# üìÖ 2026-02-07 (Part 4): Pathway Activity Scoring (UCell)

**Script:** `10_Pathway_Scoring_UCell.R`
**Status:** ‚úÖ SUCCEEDED (Dependencies fixed via BiocManager)

## üéØ 1. Objective
To quantify specific biological states (Senescence, EMT, Hypoxia) across cell types, specifically asking: *"How 'stressed' are the ADI cells compared to normal AT2?"*

## üõ†Ô∏è 2. Methodology
* **Tool:** `UCell` (Rank-based scoring, robust to batch effects).
* **Gene Sets:**
    * **ADI Signature:** (Krt8, Cldn4...) - Positive control.
    * **EMT:** (Vim, Fn1, Twist1...) - Fibrosis indicator.
    * **Senescence:** (Cdkn2a, Il6...) - Aging/SASP indicator.
    * **Hypoxia:** (Hif1a, Vegfa...) - Metabolic stress.

## üß¨ 3. Key Findings (from Violin Plots)
* **Validation:** Fibroblasts showed the highest **EMT scores**, validating the gene set accuracy.
* **The ADI Phenotype:**
    * **Partial EMT:** Krt8 ADI cells exhibit significantly higher EMT scores than AT2 cells, confirming their transition towards a mesenchymal state.
    * **Senescence & Hypoxia:** ADI cells are distinctively marked by high Hypoxia and Senescence scores, suggesting they are "stuck" in a stressed, non-regenerative state.
    * **Inflammation:** High inflammatory scores align with the previous CellChat finding (Mif/Spp1 secretion).

## üìä 4. Output Files
* üñºÔ∏è `Pathway_UCell_Violin.png`: Shows the stepwise elevation of stress markers from AT2 -> ADI.
* üñºÔ∏è `Pathway_UCell_UMAP.png`: Visualizes the spatial restriction of these states.

> **Conclusion:** The AT2-to-ADI transition is not just a change in markers (Krt8+), but a fundamental shift in cell state involving **metabolic reprogramming (Hypoxia)**, **cell cycle arrest (Senescence)**, and **fibrogenic activation (EMT)**.
